Arterial Hypertension
A critical analysis of survival in pulmonary arterial hypertension
... Pulmonary arterial hypertension (PAH) is a rare disease characterised by a progressive increase in pulmonary vascular resistance, leading to right heart failure and premature ...
5
Future perspectives in pulmonary arterial hypertension
... Pulmonary arterial hypertension (PAH) has evolved from a disease with limited treatment options to one where numerous therapies that target three key pathophysiological pathways in the disease ...
9
The right ventricle in pulmonary arterial hypertension
... ABSTRACT Pulmonary arterial hypertension (PAH) is a right heart failure syndrome. In early-stage PAH, the right ventricle tends to remain adapted to afterload with increased contractility and little or no ...
12
Risk assessment in pulmonary arterial hypertension
... pulmonary arterial hypertension ...pulmonary hypertension (PH) guidelines, and the application of risk equations and scores, such as the French registry risk equation and the REVEAL registry risk ...
9
Pulmonary Arterial Hypertension and Risks of Progression
... pulmonary arterial hypertension is based on epidemiological studies, include concepts such as “target blood pressure”, which is the same for patients of all ages - less than 140 ...
8
Novel biomarkers for pulmonary arterial hypertension
... Pulmonary arterial hypertension (PAH) is a rare yet deadly disease with many causes ranging from idiopathic to secondary to many underlying pathologies including congenital heart ...
10
FOCUS ON Pulmonary Arterial Hypertension (PAH)
... Pulmonary Hypertension Association (PHA) and Washington University School of Medicine, Continuing Medical Education are pleased to present this continuing medical education (CME) initiative, bringing ...
12
Pulmonary Arterial hypertension and the Left Ventricle
... pulmonary arterial hypertension: this could be a first explanation for the breath- lessness symptom commonly associated with this ...pulmonary arterial hypertension, the work required to ...
24
Exertional dyspnoea in pulmonary arterial hypertension
... ABSTRACT Dyspnoea is a principal presenting symptom in pulmonary arterial hypertension (PAH), and often the most distressing. The pathophysiology of PAH is relatively well understood, with the primary ...
9
Inhaled treprostinil and pulmonary arterial hypertension
... pulmonary hypertension. Pulmonary arterial hypertension (PAH) is the subclassification of pulmonary hypertension, in which known or unknown underlying conditions lead to similar intrinsic ...
10
Ambrisentan for the treatment of pulmonary arterial hypertension
... Pulmonary arterial hypertension (PAH) is a disease of the small pulmonary arteries that is characterized by vasoconstriction and vascular remodeling (Humbert et al ...
16
The challenges in paediatric pulmonary arterial hypertension
... (arterial) hypertension, restrict or prevent inclusion in national disease registries and, in some cases, delay timely treatment ...Pulmonary Arterial Hypertension) trial, reporting ...
7
Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology
... ABSTRACT: Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) are two of the key subgroups of pulmonary hypertension. They are characterised by ...
5
Molecular pathogenesis of pulmonary arterial hypertension
... Recent investigations have suggested that it might be possible to reverse the pathology of pul- monary arterial hypertension (PAH), a disorder that can be rapidly progressive and fatal despite current ...
9
Macitentan for the treatment of pulmonary arterial hypertension
... pulmonary arterial hypertension patients with macitentan led to statistically significant improvements in functional class, exercise tolerance, and hemodynamic parameters, in addition to a reduction in ...
9
An AMPK paradox in pulmonary arterial hypertension
... Adenosine monophosphate-activated protein kinase (AMPK) is a heterotrimeric serine-threonine kinase important as a metabolic sensor for intracellular ATP levels and plays a key role in regulating cell survival and ...
5
Compliance Among Adolescents with Arterial Hypertension
... from arterial hypertension have been conducted so ...from arterial hyper- tension is considered to be one of the major causes of the low effectiveness of treatment of this dis- ease ...with ...
8
PDGF signaling in pulmonary arterial hypertension
... pulmonary arterial hypertension (PAH) includes endothelial cell dysfunction and proliferation and migration of ...pulmonary hypertension (see the related article beginning on page ...
5
Molecular pathogenesis of pulmonary arterial hypertension
... Pulmonary arterial hypertension (PAH) is diagnosed by an eleva- tion in mean pulmonary arterial (PA) pressure above 25 mmHg at rest or 30 mmHg with ...Pulmonary Hypertension in Dana Point, ...
9
Hypertension Guidelines for the management of arterial hypertension
... OF ARTERIAL HypERTENSION Figure 1 Stratification of total CV risk in categories of low, moderate, high and very high risk according to SBP and DBP and prevalence of RFs, asymptomatic OD, diabetes, CKD stage ...
11